[1 Name of Reporting Person Barron Partners LP I.R.S. Identification No. of Above Person 43-1981699 2 Check the Appropriate Box if a Member of a Group (a) [ ] (b) [ ] 3 SEC Use Only 4 Source of Funds WC Items 2(d) or 2(e) [ ] 6 Citizenship or Place of Organization Delaware Number of 7 Sole Voting Power]
[Skystar Bio-Pharmaceutical Awarded High Technology Enterprise Certificate Preferentialome Tax Rate Extended through 2011 XI'AN, CHINA, September 2, 2009ystar Bio-Pharmaceuticalmpany High Technology Enterprise Certificates are awarded to qualified enterprises that meet the following criteria: developingre intellectual property rights, receiving over 60% of their annual revenues from high-technology products/services, and perform highly technical research and development.ystar initially]
[Skystar Bio-Pharmaceutical Awarded High Technology Enterprise Certificate Preferentialome Tax Rate Extended through 2011 XI'AN, CHINA, September 2, 2009ystar Bio-Pharmaceuticalmpany High Technology Enterprise Certificates are awarded to qualified enterprises that meet the following criteria: developingre intellectual property rights, receiving over 60% of their annual revenues from high-technology products/services, and perform highly technical research and development.ystar initially]
[SCHEDULE 13D/A (Amendment 1)ystar Bio-Pharmaceuticalmpany (Name of Issuer)mmon Stock (Title of Class of Securities) 830884201 (CUSIP Number) Rebecca Baum 730 FIFTH AVENUE, 25TH FLOOR NEW YORK, NY 10019 212-359-0204 (Name,dress and Telephone Number of Person Authorized to Receive Notices andmmunications) August 25, 2009 (Date of Event which Requires Filing of this Statement) If the filing]
[SCHEDULE 13D/A (Amendment 1)ystar Bio-Pharmaceuticalmpany (Name of Issuer)mmon Stock (Title of Class of Securities) 830884201 (CUSIP Number) Rebecca Baum 730 FIFTH AVENUE, 25TH FLOOR NEW YORK, NY 10019 212-359-0204 (Name,dress and Telephone Number of Person Authorized to Receive Notices andmmunications) August 25, 2009 (Date of Event which Requires Filing of this Statement) If the filing]
[CHINA PHARMA HOLDINGS, INC. CHARTER OF THE NOMINATING AND COMPENSATION COMMITTEE OF THE BOARD OF DIRECTORS (as of August 2 6 , 200 9 ) I. Purpose The Nominating and Compensation Committee (the “Committee”) of the Board of Directors of China Pharma Holdings, Inc. (the “Company”) is established to: • Formulate goals and objectives relating to compensation payable to the]
[CHINA PHARMA HOLDINGS, INC. CHARTER OF THE NOMINATING AND COMPENSATION COMMITTEE OF THE BOARD OF DIRECTORS (as of August 2 6 , 200 9 ) I. Purpose The Nominating and Compensation Committee (the “Committee”) of the Board of Directors of China Pharma Holdings, Inc. (the “Company”) is established to: • Formulate goals and objectives relating to compensation payable to the]
[FORM S-8 REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933 BIOSTAR PHARMACEUTICALS, INC. Maryland 20-5101287 (State of other jurisdiction of incorporation or organization (I.R.S. Employer Identification No.) No. 588 Shiji Xi Road, Xianyang, Shaanxi Province, The People’s Republic of China 712046 (Zip Code) Biostar Pharmaceuticals, Inc. 2009 Incentive Stock Plan (Full Title of Plan) Mr. Ronghua Wang No. 588 Shiji] [BIOSTAR PHARMACEUTICALS, INC. 2009 INCENTIVE STOCK PLAN This Biostar Pharmaceuticals, Inc. 2009 Incentive Stock Plan Plan 1. Definitions. (a) Board " (b) Code " (c) Committee Rule 16b-3 Exchange Act " (d) Company " (e) Exchange Act " (f) Fair Market Value " (g) Grant " (h) Grant Agreement " (i) Maryland Securities Rules " (j) Option Optionee "] [August 28, 2009 Biostar Pharmaceuticals, Inc. Xianyang, Shaanxi Province The People’s Republic of China 712046 Ladies and Gentlemen: Very truly yours, Sichenzia Ross Friedman Ference LLP Title 41 EX-5.1 3 ex5-1.htm] [CONSENT OF INDEPENDENT REGISTERED ACCOUNTING FIRM We consent to the incorporation by reference in this registration statement of Biostar Pharmaceuticals, Inc. on Form S-8, of our report dated March 25, 2009 for the year ended December 31, 2008, appearing in the Annual Report on Form 10-K of Biostar Pharmaceuticals, Inc. Morgenstern, Svoboda & Baer CPA’s P.C. New York, New York]
[CHINA PHARMAS, CHARTER OF THE NOMINATING ANDMPENSATIONMMITTEE OF THE BOARD OF DIRECTORS (as of August 2 6 , 200 9 ) I.Purpose The Nominating andmpensationmmittee (themmittee) of the Board of Directors of China Pharmas, (thempany) is established to: Formulate goals and objectives relating tompensation payable to thempanys Chief Executive Officer (CEO) and, innsultation with the]
[CHINA PHARMAS, CHARTER OF THE NOMINATING ANDMPENSATIONMMITTEE OF THE BOARD OF DIRECTORS (as of August 2 6 , 200 9 ) I.Purpose The Nominating andmpensationmmittee (themmittee) of the Board of Directors of China Pharmas, (thempany) is established to: Formulate goals and objectives relating tompensation payable to thempanys Chief Executive Officer (CEO) and, innsultation with the]
